Daytime intragastric acid control: post hoc analyses of esomeprazole 20 mg and over-the-counter proton-pump inhibitors.

about

Clinical Implications of Emerging Data on the Safety of Proton Pump Inhibitors.The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus.Editorial: refractory GERD-good drug, wrong patients? Authors' reply.

P2860

Q31157434-8E4E8E8E-79C4-44D1-A65B-D7FBEA7D9849 Q37709906-12608196-7FA4-4CD8-A100-B23E246C417B Q48267528-896D13E7-FDA0-431D-8F11-FBA51932930C

P2860

Daytime intragastric acid control: post hoc analyses of esomeprazole 20 mg and over-the-counter proton-pump inhibitors.

Item

http://www.wikidata.org/entity/Q36212184

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Daytime intragastric acid cont ...... ounter proton-pump inhibitors.

@ast

Daytime intragastric acid cont ...... ounter proton-pump inhibitors.

@en

type

Item

label

Daytime intragastric acid cont ...... ounter proton-pump inhibitors.

@ast

Daytime intragastric acid cont ...... ounter proton-pump inhibitors.

@en

prefLabel

Daytime intragastric acid cont ...... ounter proton-pump inhibitors.

@ast

Daytime intragastric acid cont ...... ounter proton-pump inhibitors.

@en

P1476

Daytime intragastric acid cont ...... ounter proton-pump inhibitors.

@en

P2093

Barry Traxler

http://www.w3.org/2001/XMLSchema#string

David A Johnson

http://www.w3.org/2001/XMLSchema#string

John Dent

http://www.w3.org/2001/XMLSchema#string

Kerstin Röhss

http://www.w3.org/2001/XMLSchema#string

Peter J Kahrilas

http://www.w3.org/2001/XMLSchema#string

Philip Katz

http://www.w3.org/2001/XMLSchema#string

Tore Lind

http://www.w3.org/2001/XMLSchema#string

Vincent Hugo

http://www.w3.org/2001/XMLSchema#string

P2860

Esomeprazole provides improved acid control vs. omeprazole In patients with symptoms of gastro-oesophageal reflux disease.

Pharmacokinetic studies with esomeprazole, the (S)-isomer of omeprazole.

Relative potency of proton-pump inhibitors-comparison of effects on intragastric pH.

Control of intragastric pH and its relationship to gastroesophageal reflux disease outcomes.

Systematic review: patterns of reflux-induced symptoms and esophageal endoscopic findings in large-scale surveys.

Systematic review: relationships between sleep and gastro-oesophageal reflux.

Clinical trial: esomeprazole for moderate-to-severe nighttime heartburn and gastro-oesophageal reflux disease-related sleep disturbances.

Effect of esomeprazole on nighttime heartburn and sleep quality in patients with GERD: a randomized, placebo-controlled trial.

Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease-- an analysis based on the ProGERD initiative.

Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice.

P304

322-330

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1756283X15592583

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26557888

http://www.w3.org/2001/XMLSchema#string

P932

4622284

http://www.w3.org/2001/XMLSchema#string

Daytime intragastric acid control: post hoc analyses of esomeprazole 20 mg and over-the-counter proton-pump inhibitors.

about

P2860

P2860

Daytime intragastric acid control: post hoc analyses of esomeprazole 20 mg and over-the-counter proton-pump inhibitors.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932